Nicholas Hoffman & Company LLC. raised its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,063 shares of the pharmacy operator’s stock after purchasing an additional 713 shares during the period. Nicholas Hoffman & Company LLC.’s holdings in Walgreens Boots Alliance were worth $232,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the business. Islay Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $29,000. Americana Partners LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $29,000. Private Ocean LLC bought a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $25,000. West Bancorporation Inc. bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $39,000. Finally, Pacifica Partners Inc. bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $42,000. Institutional investors own 58.03% of the company’s stock.
WBA has been the subject of several research reports. Deutsche Bank raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and reduced their price objective for the company from $51.00 to $43.00 in a research report on Friday, April 3rd. UBS Group raised Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and cut their price objective for the company from $49.00 to $44.00 in a report on Monday, April 6th. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a report on Tuesday, February 25th. Finally, Barclays cut their price objective on Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating on the stock in a report on Friday, April 3rd. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $51.21.
Shares of NASDAQ:WBA traded down $0.15 during trading on Friday, hitting $39.60. 3,378,765 shares of the company were exchanged, compared to its average volume of 7,383,946. The stock has a market cap of $34.87 billion, a price-to-earnings ratio of 6.87, a P/E/G ratio of 1.83 and a beta of 0.55. Walgreens Boots Alliance Inc has a fifty-two week low of $36.65 and a fifty-two week high of $64.50. The firm has a fifty day moving average price of $42.22 and a two-hundred day moving average price of $51.33. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 1.34.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.46 by $0.06. The firm had revenue of $35.82 billion for the quarter, compared to analyst estimates of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.64 EPS. As a group, research analysts predict that Walgreens Boots Alliance Inc will post 5.53 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be given a dividend of $0.4575 per share. This represents a $1.83 annualized dividend and a dividend yield of 4.62%. The ex-dividend date is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.55%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Candlestick
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.